Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radium-223 in mCPRC patients: a large real-life Italian multicenter study.
Frantellizzi V, Monari F, Mascia M, Costa RP, Rubini G, Spanu A, Farcomeni A, Lodi Rizzini E, Cindolo L, Tripoli V, Lavelli V, Nuvoli S, Pontico M, Dionisi V, Ferrari C, DE Vincentis G. Frantellizzi V, et al. Among authors: cindolo l. Minerva Urol Nephrol. 2022 Feb;74(1):21-28. doi: 10.23736/S2724-6051.20.03808-4. Epub 2020 Aug 4. Minerva Urol Nephrol. 2022. PMID: 32748619 Free article.
Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction.
Cindolo L, Natoli C, De Nunzio C, De Tursi M, Valeriani M, Giacinti S, Micali S, Rizzo M, Bianchi G, Martorana E, Scarcia M, Ludovico GM, Bove P, Laudisi A, Selvaggio O, Carrieri G, Bada M, Castellan P, Topazio L, Boccasile S, Ditonno P, Chiodini P, Schips L. Cindolo L, et al. Clin Genitourin Cancer. 2017 Oct;15(5):520-525. doi: 10.1016/j.clgc.2017.04.003. Epub 2017 Apr 11. Clin Genitourin Cancer. 2017. PMID: 28478884 Clinical Trial.
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort.
Ferriero M, Mastroianni R, De Nunzio C, Cindolo L, Calabrò F, Tema G, Leonardo C, Flammia RS, Tuderti G, Anceschi U, Brassetti A, Giacinti S, Guaglianone S, Ghahhari J, Schips L, Tubaro A, Gallucci M, Simone G. Ferriero M, et al. Among authors: cindolo l. World J Urol. 2020 Jul;38(7):1757-1764. doi: 10.1007/s00345-019-02974-6. Epub 2019 Oct 12. World J Urol. 2020. PMID: 31605196
Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study.
Frantellizzi V, Costa R, Mascia M, Spanu A, Farcomeni A, Licari M, Cindolo L, Nuvoli S, Pontico M, De Vincentis G. Frantellizzi V, et al. Among authors: cindolo l. Clin Genitourin Cancer. 2020 Jun;18(3):185-191. doi: 10.1016/j.clgc.2019.10.009. Epub 2019 Oct 16. Clin Genitourin Cancer. 2020. PMID: 32173355
Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses.
Reale G, Marchioni M, Altieri V, Greco F, De Nunzio C, Destefanis P, Ricciardulli S, Bergamaschi F, Fasolis G, Varvello F, Voce S, Palmieri F, Divan C, Malossini G, Oriti R, Tuccio A, Ruggera L, Tubaro A, Delicato G, Laganà A, Dadone C, De Rienzo G, Ditonno A, Frattini A, Pucci L, Carrino M, Montefiore F, Germani S, Miano R, Schips L, Rabito S, Ferrari G, Cindolo L. Reale G, et al. Among authors: cindolo l. Minerva Urol Nefrol. 2020 Oct;72(5):622-628. doi: 10.23736/S0393-2249.20.03597-3. Epub 2020 Apr 10. Minerva Urol Nefrol. 2020. PMID: 32284526 Free article.
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study.
Gacci M, Marchioni M, DE Francesco P, Natoli C, Calabrò F, Losanno T, Gianmartin C, Serni S, Doni L, DE Nunzio C, DE Tursi M, Valeriani M, Giacinti S, Álvarez-Maestro M, Scarcia M, Ludovico GM, Del Bene G, Simone G, Ferriero M, Tuderti G, Bove P, Laudisi A, Carrieri G, Cormio L, Verze P, LA Rocca R, Falsaperla M, Frantellizzi V, Greco F, DI Nicola M, Schips L, Cindolo L. Gacci M, et al. Among authors: cindolo l. Minerva Urol Nephrol. 2021 Aug;73(4):489-497. doi: 10.23736/S2724-6051.20.03723-6. Epub 2020 Aug 4. Minerva Urol Nephrol. 2021. PMID: 32748613 Free article.
Ultrasound prostate parameters as predictors of successful trial without catheter after acute urinary retention in patients ongoing medical treatment for benign prostatic hyperplasia: a prospective multicenter study.
DE Nunzio C, Voglino O, Cicione A, Tema G, Cindolo L, Bada M, Lombardo R, Nacchia A, Trucchi A, Ships L, Gacci M, Milanesi M, Cito G, Serni S, Tubaro A. DE Nunzio C, et al. Among authors: cindolo l. Minerva Urol Nephrol. 2021 Oct;73(5):625-630. doi: 10.23736/S2724-6051.20.04088-6. Epub 2020 Nov 17. Minerva Urol Nephrol. 2021. PMID: 33200904 Free article.
Green light laser enucleation of the prostate with early apical release is safe and effective: single center experience and revision of the literature.
Ferrari G, Rabito S, Gatti L, Ntep NN, Vitelli FD, Marchioni M, Rocco BM, Micali S, Ferrari R, Cindolo L. Ferrari G, et al. Among authors: cindolo l. Minerva Urol Nephrol. 2022 Aug;74(4):467-474. doi: 10.23736/S2724-6051.21.04145-X. Epub 2021 Mar 29. Minerva Urol Nephrol. 2022. PMID: 33781016 Free article.
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study).
Bauckneht M, Rebuzzi SE, Signori A, Frantellizzi V, Murianni V, Lodi Rizzini E, Mascia M, Lavelli V, Donegani MI, Ponzano M, Gaudiano A, Stazza ML, Licari M, Cavallini L, Laghi V, Cindolo L, Maggi M, Sciarra A, Mammucci P, Sambuceti G, Costa RP, Spanu A, Rubini G, Monari F, De Vincentis G, Fornarini G. Bauckneht M, et al. Among authors: cindolo l. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1063-1074. doi: 10.1007/s00259-021-05550-6. Epub 2021 Sep 6. Eur J Nucl Med Mol Imaging. 2022. PMID: 34486070 Free PMC article.
275 results